Health Care [ 9/12 ] | Pharmaceuticals [ 62/76 ]
NASDAQ | Common Stock
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases.
The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1.
It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis.
Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 9, 24 | 0.00 Increased by +100.00% | -0.07 Increased by +100.00% |
| Mar 14, 24 | -0.09 Decreased by -325.00% | -0.04 Decreased by -125.00% |
| Nov 9, 23 | -0.02 Increased by +83.33% | -0.10 Increased by +80.00% |
| Aug 10, 23 | 0.15 Increased by +350.00% | -0.09 Increased by +266.67% |
| May 11, 23 | -0.10 Increased by +52.38% | -0.14 Increased by +28.57% |
| Mar 16, 23 | 0.04 Increased by 0.00% | 0.01 Increased by +300.00% |
| Nov 10, 22 | -0.12 Increased by +50.00% | -0.15 Increased by +20.00% |
| Aug 11, 22 | -0.06 Increased by +40.00% | 0.03 Decreased by -300.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 7.31 M Decreased by -13.94% | -2.26 M Decreased by -347.37% | Decreased by -30.85% Decreased by -387.45% |
| Sep 30, 23 | 7.03 M Increased by +118.33% | -579.00 K Increased by +81.88% | Decreased by -8.24% Increased by +91.70% |
| Jun 30, 23 | 12.00 M Increased by +63.05% | 4.56 M Increased by +356.70% | Increased by +38.00% Increased by +257.44% |
| Mar 31, 23 | 5.30 M Increased by +143.75% | -2.91 M Increased by +47.75% | Decreased by -54.90% Increased by +78.56% |
| Dec 31, 22 | 8.50 M Increased by +39.47% | 912.00 K Decreased by -12.22% | Increased by +10.73% Decreased by -37.06% |
| Sep 30, 22 | 3.22 M Increased by +315.35% | -3.19 M Increased by +47.57% | Decreased by -99.25% Increased by +87.38% |
| Jun 30, 22 | 7.36 M Increased by +139.91% | -1.78 M Increased by +11.90% | Decreased by -24.14% Increased by +63.28% |
| Mar 31, 22 | 2.18 M Decreased by -81.71% | -5.57 M Decreased by -208.93% | Decreased by -256.11% Decreased by -695.58% |